Targeting the transcriptional machinery of Enhancer-Mediator-Promoter licenses/potentiates CD8+ T cell stemness and anti-tumor immunity
WT and Med1 KO OT-1+CD8+ T cells were isolated from recipient mice 14 days after OVA immunized in the in vivo co-transfer model.